Gene scissors switch off with built-in timer

Gene scissors switch off with built-in timer: (from left) PD Dr. Gregor Hagelueken, Sophie Binder and Niels Schneberger clarify self-regulation of the immune response in the CRISPR bacterial defense system.
Photo: Rolf Müller /
University Hospital Bonn (UKB)

Bonn researchers clarify self-regulation of the immune response in the CRISPR bacterial defense system: CRISPR gene scissors, as new tools of molecular biology, have their origin in an ancient bacterial immune system. But once a virus attack has been successfully overcome, the cell has to recover. Researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with researchers from the Institut Pasteur in France, have discovered a timer integrated into the gene scissors that enables the gene scissors to switch themselves off. The results of the study have been published in the renowned journal “Nucleic Acids Research”.

Some bacteria have developed CRISPR gene scissors in response to attacks by so-called phages. This bacterial immune system recognizes the phage genetic material, destroys it and thus protects against viral attacks. When detecting phages, the type III variants of these immune systems produce messenger substances with cyclic oligoadenylates (cOAs), which the bacteria use to switch on a complex emergency plan. This ensures that a virus can be fought optimally and on a broad front. A research team led by PD Dr. Gregor Hagelueken from the Institute of Structural Biology at the UKB, who is a member of the Transdisciplinary Research Area (TRA) “Life & Health” and the Cluster of Excellence ImmunoSensation2 at the University of Bonn, discovered that the messenger substance cA4 produced by the gene scissors binds to a protein called CalpL. The protein scissors activated in this way trigger a signaling cascade that helps the cell to survive the viral attack.

The Bonn researchers had thus uncovered a completely new aspect of CRISPR systems, which can be easily reprogrammed for biotechnological and medical purposes. “These CRISPR-activated protein scissors that we discovered are a brand new tool in the toolbox of molecular biology,” says Niels Schneberger, a doctoral student at the University of Bonn’s Institute of Structural Biology at the UKB, who played a key role in the discovery of the CalpL protein.

Cellular recovery by limiting the antiviral response

“After a viral attack, however, it is crucial to eliminate the remaining cyclic oligoadenylates in order to terminate the antiviral reaction and return the cell to its normal state,” says Sophie Binder, who shares the first authorship of the study with Schneberger and is also a doctoral student at the University of Bonn’s Institute of Structural Biology at the UKB. In cooperation with researchers from the Institut Pasteur in Paris and the Kekulé Institute for Organic Chemistry and Biochemistry at the University of Bonn, the Bonn researchers have now been able to show that the so-called SAVED domain of the CalpL protease has a ring nuclease activity that cleaves cA4. “The protein therefore contains something like a molecular timer that switches off the immune reaction. By breaking down cA4 into linear fragments, the duration of the immune response is regulated, which enables a controlled return of the cell to normal conditions,” says Binder.

A switchable protease such as CalpL is also of great interest for biotechnological applications. For example, it could be used as a molecular sensor. “The newly discovered ring nuclease activity is actually a disadvantage for such purposes,” says PD Dr. Hagelueken. “However, in our study, we were also able to show how ring nuclease activity can be specifically inhibited so that the sensor does not switch itself off again.”

Funding and participating institutions:
The project was funded by the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Bonn. In addition to the Institute of Structural Biology at the UKB, the Kekulé Institute of Organic Chemistry and Biochemistry at the University of Bonn and the Institut Pasteur, Paris, France, are also involved in the study.

Publication: Sophie C. Binder, Niels Schneberger, Marianne Engeser, Matthias Geyer, Christophe Rouillon, Gregor Hagelueken: The SAVED domain of the type III CRISPR protease CalpL is a ring nuclease; Nucleic Acids Research,
DOI: 10.1093/nar/gkae676/7737999
Link to publication: https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkae676/7737999

Press contact:
Dr. Inka Väth
Deputy Press Officer at the University Hospital Bonn (UKB)
Communications and Media Office at Bonn University Hospital
Phone: (+49) 228 287-10596
E-mail: inka.vaeth@ukbonn.de

About Bonn University Hospital: The UKB treats around 500,000 patients per year, employs around 9,500 staff and has total assets of 1.8 billion euros. In addition to the 3,500 medical and dental students, 550 people are trained in numerous healthcare professions each year. The UKB is ranked first among university hospitals (UK) in NRW in the Focus Clinic List, had over 100 million third-party funds in research in 2023 and has the second highest case mix index (case severity) in Germany. The F.A.Z. Institute awarded the UKB first place among university hospitals in the category “Germany’s training champions 2024”.

Wissenschaftliche Ansprechpartner:

PD Dr. Gregor Hagelueken
Institute of Structural Biology
Bonn University Hospital
ImmunoSensation2 &TRA “Life & Health”, University of Bonn
Phone: +49 228 287-51200
E-mail: hagelueken@uni-bonn.de

Originalpublikation:

Sophie C. Binder, Niels Schneberger, Marianne Engeser, Matthias Geyer, Christophe Rouillon, Gregor Hagelueken: The SAVED domain of the type III CRISPR protease CalpL is a ring nuclease; Nucleic Acids Research,
DOI: 10.1093/nar/gkae676/7737999

Weitere Informationen:

https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gkae676/7737999 Publication

http://www.ukbonn.de

Media Contact

Dr. Inka Väth Kommunikation und Medien
Universitätsklinikum Bonn

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Illuminating quantum magnets: Light unveils magnetic domains

Scientists visualize and control magnetic domains in quantum antiferromagnets. When something draws us in like a magnet, we take a closer look. When magnets draw in physicists, they take a…

Researchers discover new plutonium isotope

A research team led by researchers at the Institute of Modern Physics (IMP) of the Chinese Academy of Sciences (CAS) has synthesized a new plutonium isotope, plutonium-227. This study was published in Physical…

Let there be light: Bright future for solar panels, TV screens and more

From brighter TV screens to better medical diagnostics and more efficient solar panels, new Curtin-led research has discovered how to make more molecules stick to the surface of tiny nanocrystals,…

Partners & Sponsors